在复发性耐火性多发性髓瘤中使用CAR-T疗法
Current medicinal chemistry
|October 2, 2023
概括
化学抗原受体T细胞疗法为复发性耐火性多发性骨髓瘤患者提供了新的希望,克服了对标准治疗的耐药性并改善了预后. 组合疗法可以进一步提高疗效,并防止获得的耐药性.
科学领域:
- 血液学 血液学 血液学
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
背景情况:
- 多发性骨髓瘤是一种血细胞瘤,在复发/耐药病例中改善但仍然有限的治疗选择.
- 传统疗法,如蛋白酶体抑制剂和免疫调节药物,在晚期或复发性耐火性多发性骨髓瘤中表现出有限的疗效.
- 新兴的治疗方法,如抗CD38单克隆抗体,已经改善了治疗结果,但药物耐药性和复发的挑战仍然存在.
研究的目的:
- 对复发性耐火性多发性骨髓瘤的化学抗原受体T细胞 (CAR-T) 治疗产品进行审查.
- 阐明CAR-T疗法中耐药性的机制,并探索改善策略.
- 确定CAR-T治疗的最佳候选人,并讨论治疗后的救援治疗方法.
主要方法:
- 对仿真抗原受体T细胞产品和临床试验数据的文献综述.
- 在多发性骨髓瘤中对CAR-T疗法特有的耐药性机制的分析.
- 综合有关患者选择和治疗后管理策略的信息.
主要成果:
- 化学抗原受体T细胞疗法在三重耐药多发性骨髓瘤患者中显示出有前途的快速缓解率.
- 卡特-T疗法可以克服对新型药物的耐药性,为具有挑战性的病例提供潜在的解决方案.
- 了解耐药机制对于优化CAR-T疗效和开发组合策略至关重要.
结论:
- 化学抗原受体T细胞疗法对复发性耐火性多发性骨髓瘤具有显著的进步,特别是在重度预治疗的患者中.
- 组合免疫疗法有潜力减轻获得的耐药性并改善长期结果.
- 对CAR-T疗法优化和救援策略的进一步研究有必要进行临床应用.
相关概念视频
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Tumor Immunotherapy
551
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
551
Stem Cell Therapy for Tissue Regeneration
4.1K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.1K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
![Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F62334.jpg&w=3840&q=50)

